Benefits of utilizing gene-modified iPSCs for clinical applications

James Ellis, Christopher Baum, Nissim Benvenisty, Gustavo Mostoslavsky, Hideyuki Okano, William L. Stanford, Matthew Porteus, Michel Sadelain

Research output: Contribution to journalArticle

17 Citations (Scopus)
Original languageEnglish
Pages (from-to)429-430
Number of pages2
JournalCell Stem Cell
Volume7
Issue number4
DOIs
Publication statusPublished - 2010 Oct 8

Fingerprint

Induced Pluripotent Stem Cells
Gene Transfer Techniques
Safety
Genes

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Medicine
  • Genetics

Cite this

Ellis, J., Baum, C., Benvenisty, N., Mostoslavsky, G., Okano, H., Stanford, W. L., ... Sadelain, M. (2010). Benefits of utilizing gene-modified iPSCs for clinical applications. Cell Stem Cell, 7(4), 429-430. https://doi.org/10.1016/j.stem.2010.09.010

Benefits of utilizing gene-modified iPSCs for clinical applications. / Ellis, James; Baum, Christopher; Benvenisty, Nissim; Mostoslavsky, Gustavo; Okano, Hideyuki; Stanford, William L.; Porteus, Matthew; Sadelain, Michel.

In: Cell Stem Cell, Vol. 7, No. 4, 08.10.2010, p. 429-430.

Research output: Contribution to journalArticle

Ellis, J, Baum, C, Benvenisty, N, Mostoslavsky, G, Okano, H, Stanford, WL, Porteus, M & Sadelain, M 2010, 'Benefits of utilizing gene-modified iPSCs for clinical applications', Cell Stem Cell, vol. 7, no. 4, pp. 429-430. https://doi.org/10.1016/j.stem.2010.09.010
Ellis J, Baum C, Benvenisty N, Mostoslavsky G, Okano H, Stanford WL et al. Benefits of utilizing gene-modified iPSCs for clinical applications. Cell Stem Cell. 2010 Oct 8;7(4):429-430. https://doi.org/10.1016/j.stem.2010.09.010
Ellis, James ; Baum, Christopher ; Benvenisty, Nissim ; Mostoslavsky, Gustavo ; Okano, Hideyuki ; Stanford, William L. ; Porteus, Matthew ; Sadelain, Michel. / Benefits of utilizing gene-modified iPSCs for clinical applications. In: Cell Stem Cell. 2010 ; Vol. 7, No. 4. pp. 429-430.
@article{050aab29023442d89af1aa73749abe9d,
title = "Benefits of utilizing gene-modified iPSCs for clinical applications",
author = "James Ellis and Christopher Baum and Nissim Benvenisty and Gustavo Mostoslavsky and Hideyuki Okano and Stanford, {William L.} and Matthew Porteus and Michel Sadelain",
year = "2010",
month = "10",
day = "8",
doi = "10.1016/j.stem.2010.09.010",
language = "English",
volume = "7",
pages = "429--430",
journal = "Cell Stem Cell",
issn = "1934-5909",
publisher = "Cell Press",
number = "4",

}

TY - JOUR

T1 - Benefits of utilizing gene-modified iPSCs for clinical applications

AU - Ellis, James

AU - Baum, Christopher

AU - Benvenisty, Nissim

AU - Mostoslavsky, Gustavo

AU - Okano, Hideyuki

AU - Stanford, William L.

AU - Porteus, Matthew

AU - Sadelain, Michel

PY - 2010/10/8

Y1 - 2010/10/8

UR - http://www.scopus.com/inward/record.url?scp=77957359122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957359122&partnerID=8YFLogxK

U2 - 10.1016/j.stem.2010.09.010

DO - 10.1016/j.stem.2010.09.010

M3 - Article

C2 - 20887948

AN - SCOPUS:77957359122

VL - 7

SP - 429

EP - 430

JO - Cell Stem Cell

JF - Cell Stem Cell

SN - 1934-5909

IS - 4

ER -